Home Blog Page 3607

VESTIAIRE COLLECTIVE PARTNERS WITH PARIS HILTON FOR CLOSET SALE FEATURING ICONIC LOOKS WITH PROCEEDS BENEFITING HILTON’S NONPROFIT 11:11 MEDIA IMPACT

NEW YORK, Feb. 19, 2025 /PRNewswire/ — Vestiaire Collective, the leading global platform for pre-loved luxury fashion, announces its latest celebrity closet sale with OG influencer, entrepreneur, innovator, and philanthropist Paris Hilton with net proceeds benefiting her nonprofit, 11:11 Media Impact and their efforts to support relief for the LA fires, where she’s been leveraging her platform to raise awareness, provide resources, and assist affected communities.

Vestiaire Collective x Paris Hilton
Vestiaire Collective x Paris Hilton

As a certified B-Corp, Vestiaire Collective is partnering with Hilton, a longtime circular fashion advocate, on this exclusive charity sale, selling nearly 100 pre-loved pieces directly from Hilton’s personal closet that showcase her iconic style and fashion evolution, from socialite to modern business mogul.

The sale is a unique opportunity to own pieces from a bona fide fashion icon, including a Juicy Couture velour tracksuit, Paris Hilton-signed slogan T-shirts and Von Dutch jacket, bedazzled denim jackets with “Paris Hilton” embroidered on the back, and a vintage Takashi Murakami x Louis Vuitton bag. Among other standouts are a Miu Miu studded biker jacket, her signature mini dresses from brands such as Lanvin, Mugler, Self-Portrait, and Zhivago, and a selection of handbags and shoes from Balenciaga, Versace, and Giuseppe Zanotti. Max Mara has also lent their support to the sale by donating the Max Mara 101801 topcoat, a timeless piece that Paris has reworn, while Pamella Roland, a longtime supporter of Hilton, has donated an evening dress. Prices range from $75 to $2250 and will be available to purchase globally.

“I’ve always embraced taking risks and having fun with fashion. I hope the pieces in my closet inspire others to experiment with their style and celebrate originality. This sale will support my charity’s work around relief efforts for the devastating LA fires and our ongoing mission to protect vulnerable youth from child abuse and bring hope to those in need. I can’t think of a better way to combine my greatest passions, fashion and charity, than with a closet sale. I’m so thankful to Vestiaire Collective for championing not only charitable causes but also pushing consumers to make fun, iconic fashion choices,” says Hilton, CEO of 11:11 Media Impact.

Net proceeds from the sale will be donated to 11:11 Media Impact, a non-profit founded by Hilton to protect children globally, historically focusing on ending institutional child abuse due to Paris’s lived-experience. Hilton, a vocal advocate for the issue, played a key role in passing the Stop Institutional Child Abuse Act in December 2024 which requires greater transparency of youth residential treatment facilities in the United States. As a resident of Los Angeles, Hilton has been actively supporting the California wildfire recovery efforts through 11:11 Media Impact. The proceeds of the closet sale will also go towards providing financial assistance to families who have lost their homes, providing short-term housing, and daily essentials.

“Fashion has the power to tell stories of self-expression and identity, and our closet sales have always been about celebrating trailblazers. Paris is a true icon, inspiring us not only with her bold style, but also with her courage to share her personal story to spark change. As pioneers in the fashion industry, committed to creating a more sustainable future, we are proud to collaborate with Paris, a changemaker advocating for the rights of children and teens,” says Co-founder and President of Vestiaire Collective, Fanny Moizant.

The sale also features unique content across Paris Hilton’s personal channels and Vestiaire Collective-owned channels, including an interview with Hilton and editorial content on the main homepage, as well as dedicated e-mails and curated shopping features.

Founded in Paris in 2009, Vestiaire Collective stands out by offering its global community of fashion lovers access to one-of-a-kind wardrobes from around the world, as well as maintaining official partnerships with some of the biggest names in luxury fashion, including Burberry, Gucci, Chloé, and more.

With over 5 million items in the catalog and 30,000 new listings daily, Vestiaire Collective has become the top choice to buy and sell pre-loved luxury fashion. With monthly celebrity, influencer, and tastemaker closet sales, Vestiaire Collective offers its millions of members access to coveted closets from all around the world, like Hilton’s, with previous celebrity closet sales including Jessica Chastain, Laura Dern, Chloe Fineman, Kim Kardashian, Jessica Alba, Candace Bushnell, Karen Elson, and more.

This partnership with Hilton is part of the company’s ambitious growth strategy in the United States and follows another major pop culture moment for the brand: its 2024 feature in Season 4 of Emily in Paris. The United States is now Vestiaire Collective’s largest market, representing 20% of its total business.

Campaign imagery: HERE
Product imagery: HERE
Discover the Paris Hilton closet sale: HERE
Discover the Paris Hilton edit to get her look: HERE 
Learn about 11:11 Media Impact: HERE  

About Vestiaire Collective

Vestiaire Collective is the leading global platform for pre-loved luxury fashion. The company’s mission is to transform the fashion industry for a more sustainable future, through empowering its community to shop more consciously. Driven by the philosophy ‘Think First, Buy Second’, Vestiaire Collective offers a trusted space for its community to prolong the life of its most-loved fashion pieces. The platform’s innovative features simplify the selling and buying process, as well as giving its members access to one-of-a-kind wardrobes from around the world. The company boasts a curation of 5 million desirable items. Co-founded in 2009 by two female entrepreneurs in Paris, Vestiaire Collective is a Certified B Corporation® and is active in 70 countries worldwide.

About 11:11 Media Impact

11:11 Media Impact, founded by Paris Hilton, is a nonprofit organization dedicated to creating meaningful and lasting change worldwide. Rooted in Paris’s lived experiences, the organization leverages strategic advocacy, socially-conscious storytelling, and philanthropic investments to address critical issues such as protecting children from institutional child abuse and fostering inclusion for individuals with learning and thinking differences.

Since its inception, 11:11 Media Impact has achieved significant milestones, including the passage of the federal Stop Institutional Child Abuse Act, the enactment of 10 U.S. state laws safeguarding youth in residential treatment facilities, and the successful repatriation of American children from abusive facilities abroad. In addition to its child protection work, Paris has been a passionate advocate for ADHD awareness and a steadfast supporter of LGBTQIA+ direct service organizations.

With over 21.5 billion earned media impressions in 2024 alone, 11:11 Media Impact harnesses innovative strategies and Paris’s global influence to drive systemic change, deliver justice for survivors, and protect vulnerable children around the world.

pr@vestiairecollective.com 

 

 

Captiva Announces Mark Rodd Joins Advisory Board of MDC to Lead Indigenous Tourism and Hospitality Development on Mi’kmaq-Owned Land


VANCOUVER, BRITISH COLUMBIA – Newsfile Corp. – 19 February 2025 – Captiva Verde Wellness Corp. (CSE: PWR) (OTC Pink: CPIVF) (“Captiva Verde”) a public company listed on the Canadian Securities Exchange under the trading symbol PWR and further listed in the US OTC Market under the symbol CPIVF announces that Mark Rodd, a leader in the hospitality and tourism industry, has joined the Advisory Board of Matnaggewinu Development Corporation (MDC). Mark will play a pivotal role in the development of a 55-acre Indigenous-owned property, guiding its transformation into a premier tourism and hospitality destination rooted in Mi’kmaq culture and tradition.

Mark Rodd is the CEO of Rodd Hotels and Resorts, Atlantic Canada’s leading resort chain, operating numerous hotels across the region renowned for exceptional guest experiences and the promotion of regional tourism. With decades of experience in the hospitality sector, Mark brings a wealth of expertise in destination development, tourism strategy, and luxury resort operations. His proven track record in creating iconic tourism destinations will be invaluable in ensuring the project’s long-term success and positive contribution to the local economy.

Rodd Hotels and Resorts is recognized as the premier provider of golf resorts and hotels in Atlantic Canada. Established in 1935, the company has earned numerous accolades from major golf publications, consistently ranking as the top golf resort destination in the region and the largest independently owned hotel chain in Atlantic Canada.

Sustainability and respect for the environment are cornerstones of Rodd Hotels and Resorts’ operations, alongside a commitment to prioritizing employees and stakeholders, ensuring the organization’s longevity and continued success.

Located on ancestral Mi’kmaq land, the 55-acre development will offer a unique blend of authentic cultural experiences, luxury accommodations, and eco-tourism, reflecting the rich history and heritage of the Mi’kmaq people. The project is part of MDC’s vision to empower Indigenous communities through sustainable economic development while sharing Mi’kmaq culture with visitors from around the world.

With decades of experience in the hospitality sector, Mark Rodd brings a wealth of expertise in destination development, tourism strategy, and luxury resort operations. His track record in creating iconic tourism destinations will be invaluable in shaping the project’s long-term success and its contribution to the local economy.

“We are excited to welcome Mark Rodd to our advisory board,” said Nowlen Augustine. “His expertise in tourism development aligns perfectly with our mission to create an inspiring destination that celebrates our Mi’kmaq heritage while fostering economic growth and cultural preservation.”

The planned development will include boutique accommodations, wellness retreats, outdoor adventure activities, and cultural programs, all designed to offer visitors an immersive experience in Mi’kmaq traditions and connection to the land. The project will also prioritize environmental stewardship, ensuring the land’s natural beauty and resources are protected for future generations.

Mark Rodd commented, “It’s an honor to join MDC and be part of this transformative project. This development is not just about tourism-it’s about building a sustainable future that respects and honors Mi’kmaq culture, while creating meaningful opportunities for the community.”

On Behalf of the Board of Directors

“Jeff Ciachurski”
Jeffrey Ciachurski
Chief Executive Officer and Director
Cell: (949) 903-5906
E-mail: westernwind@shaw.ca

The issuer is solely responsible for the content of this announcement.

About Matnaggewinu Development Corporation (MDC):

MDC is a Mi’kmaq-led organization committed to advancing economic development for Mi’kmaq communities through sustainable projects and partnerships. The corporation focuses on initiatives that preserve Mi’kmaq culture while fostering economic self-reliance and prosperity.

About Captiva Verde:
Captiva is dedicated to building partnerships that support Indigenous development and economic growth in key sectors such as real estate-based hospitality, tourism, aviation and renewable resources. Matnaggewinu is 49% owned by Captiva Verde.

Neither Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Information

This news release includes “forward-looking statements” and “forward-looking information” within the meaning of Canadian securities laws and United States securities laws (together, “forward-looking statements”). All statements included in this news release, other than statements of historical fact, are forward-looking statements including, without limitation, statements with respect to the expansion of Captiva’s health and wellness platform.

Forward-looking statements include predictions, projections and forecasts and are often, but not always, identified by the use of words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, “potential”, “target”, “budget”, “propose” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions and includes the negatives thereof.

Forward-looking statements are based on a number of assumptions and estimates that, while considered reasonable by management based on the business and markets in which the Company operates, are inherently subject to significant operational, economic, and competitive uncertainties, risks and contingencies. These include assumptions regarding, among other things: general business and economic conditions. There can be no assurance that forward-looking statements will prove to be accurate and actual results, and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include those described under the heading “Risks and Uncertainties” in the Company’s most recently filed MD&A (a copy of which is available under the Company’s SEDAR profile at ). The Company does not undertake to update or revise any forward-looking statements, except in accordance with applicable law.

Speakers at Inaugural SEMIEXPO Heartland Event to Highlight Advancements in Smart Manufacturing and Smart Mobility

MILPITAS, Calif., Feb. 19, 2025 /PRNewswire/ — SEMIEXPO Heartland, SEMI’s first Midwestern U.S. exposition to be held April 1-2 at the Indiana Convention Center in Indianapolis, will feature a conference program highlighting the latest developments in smart manufacturing and smart mobility. This event will bring together leaders from both areas to explore strategies for collaboration and innovation, fostering growth and new business opportunities in this thriving hub for semiconductor manufacturing. Registration is open.


SEMIEXPO Heartland Inaugural Conference Highlights

The event will be hosted by SEMIEXPO Heartland Honorary Chairman Terry Brewer, Founder and Chairman of Brewer Science.

Keynote Speakers

  • CHIPS for America: Dev Palmer, Director, National Advanced Packaging Manufacturing Program
  • Governor of Indiana: The Honorable Mike Braun
  • Polar Semiconductor: Surya Iyer, President and COO
  • Purdue University: Mung Chiang, President
  • Robert Bosch Semiconductor: Thorsten Scheer, Regional President Mobility Electronics

Panel Session: Future of Semiconductors in the Midwest

  • Indiana Secretary of Commerce: David J. Adams
  • Michigan Economic Development Corporation: Quentin Messer Jr, President and CEO
  • JobsOhio: J.P. Nauseef, President and CEO

Smart Manufacturing Sessions will share insights on deployment for smart manufacturing tools, technologies, and methods for the assembly, package, and test (APT) areas of semiconductor manufacturing.

  • APT Innovations Unleashed
    This session will highlight advancements in chip APT techniques for current and future advanced nodes, mature nodes, and traditional and future packaging approaches. Attendees will discover how these technologies are reshaping the industry and enabling high-performance, low-power chips for applications like 5G, autonomous vehicles, and Internet of Things (IoT).
  • Smart Manufacturing for APT: Data Analytics/AI and Digital Twins
    To ensure the high-quality chips needed for a connected world, testing, yield, and optimization are essential. This session will focus on these considerations and the current state-of-the-art in APT, including wafer testing, assembly, and final packaging.
  • Robotics and Automation for APT
    Attendees will gain a deeper understanding of the transformative role that robotics and automation play in semiconductor APT. This session will highlight how cobots and robots are enhancing productivity, reducing costs, improving quality, and implementing predictive maintenance for factory operations.
  • Future OSAT and APT Factories
    As innovative wafer fabs adopt technologies like digital twins, generative AI, and machine learning, this session will highlight deployment challenges pertaining to security, upskilling talent, and sustainability.

Smart Mobility Sessions will provide a forum for addressing technical issues and supply chain dynamics related to sensors and mobility challenges. 

  • Electric Vehicles and Power Semiconductors Driving Sustainability
    Whether vehicles are hybrid-electric, battery-electric, or fuel-cell powered, different solutions like traditional silicon, IGBTs, SiC, GaN, and other advanced materials come into play. This session will explore these technologies, along with supply chain challenges, market trends, policies, and trade.
  • Chiplets Reshaping the Compute Architecture 
    Some experts see chiplets as a game-changing technology, while others view them as a new marketplace. This session will offer insights from chip makers, automotive manufacturers, suppliers, and market analysts, to put the future of chiplets into perspective.
  • Autonomous Vehicles Powered by AI Technology
    Today’s industry is experiencing both the benefits and challenges of letting computers take the wheel. This session will delve into the essential hardware for computing, sensing, and communication. Presenters will provide an update on autonomous driving technologies, as well as the semiconductors and sensors needed to bridge the gaps.
  • MEMS & Sensors, the Indispensable Source for Smart Vehicles
    With over 100 MEMS and sensors on each smart vehicle, these technologies are crucial for safety, sustainability, and convenience. This session will discuss the essential sensors for smart vehicles, their function for IoT, and how evolving specifications and regulations will impact their designs.

Workforce Development Pavilion

SEMIEXPO Heartland will include SEMI’s signature Workforce Development Pavilion to connect job seekers with employers, provide resume guidance, and offer opportunities for mentorship. The Workforce Development Pavilion will also host “day in the life” sessions, where professionals will share their career experiences in the semiconductor industry. The pavilion is free for students and recent graduates.

View the full SEMIEXPO Heartland 2025 agenda for updates on speakers and to learn more.

For press interested in attending SEMIEXPO Heartland 2025, please contact Sherrie Gutierrez at sgutierrez@semi.org.

SEMIEXPO Heartland was developed in partnership with the Indiana Economic Development Corporation, the Applied Research Institute, Purdue University, and Visit Indy.

About SEMI
SEMI® is the global industry association connecting over 3,000 member companies and 1.5 million professionals worldwide across the semiconductor and electronics design and manufacturing supply chain. We accelerate member collaboration on solutions to top industry challenges through Advocacy, Workforce Development, Sustainability, Supply Chain Management and other programs. Our SEMICON® expositions and events, technology communities, standards and market intelligence help advance our members’ business growth and innovations in design, devices, equipment, materials, services and software, enabling smarter, faster, more secure electronics. Visit www.semi.org, contact a regional office, and connect with SEMI on LinkedIn and X to learn more.  

About Indiana Economic Development Corporation
The Indiana Economic Development Corporation (IEDC) is part of the broader State of Indiana’s Commerce Office created by Governor Mike Braun and is charged with growing the state economy, driving economic development, and helping businesses launch, grow and locate in the state. Governed by a board of directors chaired by Governor Mike Braun, the IEDC manages many initiatives, including workforce development, innovation and entrepreneurship resources, public infrastructure assistance and talent attraction and retention. For more information about the IEDC, visit iedc.in.gov.

About Applied Research Institute (ARI)
Applied Research Institute (ARI) is a non-partisan leader in technology innovation and strategy. As a neutral, third-party innovation ecosystem orchestrator, ARI collaborates with cross-sectional partners from state and federal government, industry, and academia, across a wide spectrum of technology focus areas. We specialize in creating robust ecosystems, facilitating partnerships, and managing complex technology projects from start to finish – all with the goal of transforming ideas into game-changing results.

About Purdue University
Purdue University is known for its excellence, scale, and impact in semiconductor education and research. Purdue leads the 33-university SCALE network, which is developing a semiconductor workforce for the defense sector. Purdue’s Semiconductor Degrees Program, guided by 40 senior semiconductor leaders, is developing the semiconductor workforce for the commercial sector. A strong, critical mass of researchers spans the full stack of semiconductors R&D, from materials and devices, to circuits, systems, architecture, and advanced packaging integration. Led by the Atalla Institute for Advanced System Integration and Packaging, the Birck Nanotechnology Center, the Center for Secure Microelectronics Ecosystems, the Institute for CHIPS and AI, and supported by the nanoHUB infrastructure for data services and AI, Purdue plays an active role in many national R&D programs.

Visit Indy
Indy’s convention and visitor’s bureau enhances the quality of life in Indianapolis by optimizing visitor-related economic impact. As an unprecedented level of cooperation between business and government boosts Indianapolis to a completely new level, they’re reveling in the opportunity to show our city off to SEMI and the semiconductor industry community.

SEMI Contact
Sherrie Gutierrez/SEMI Corporate
Phone: 1.831.889.3800
Email: sgutierrez@semi.org

 

Sun Life Invests Over HK$10 Million to Partner with the Basketball Association of Hong Kong, China

Focusing on Three Key Areas to Develop a Professional Basketball Ecosystem and Promote a Healthy and Active Lifestyle


HONG KONG SAR – Media OutReach Newswire – 19 February 2025 – Sun Life and the Basketball Association of Hong Kong, China (BAHKC) held a partnership signing ceremony today (February 19), officially announcing an investment of over HK$10 million for a three-year collaboration. This strategic partnership will focus on three key areas: athlete support, basketball popularization, and community outreach. The initiative reflects Sun Life’s commitment to basketball development and aims to build a professional and sustainable basketball ecosystem in Hong Kong while encouraging the public to embrace an active and positive lifestyle.

Sun Life (right) and the Basketball Association of Hong Kong, China (left) held a partnership signing ceremony.
Sun Life (right) and the Basketball Association of Hong Kong, China (left) held a partnership signing ceremony.

Extending Global Basketball Support to Drive Local Basketball Development
Sun Life has been committed to promoting a healthy lifestyle and believes that basketball, as one of the world’s most popular sports, can enhance physical and mental health and community cohesion. Since 2014, Sun Life has supported the NBA’s Toronto Raptors, becoming the team’s first jersey patch sponsor in 2017. In 2023, Sun Life further strengthened its commitment to basketball by reaching a multi-year sponsorship agreement with Canada Basketball, becoming the official jersey sponsor and Official Health and Wellness Partner for Canadian men’s and women’s national teams, in line with its philosophy of promoting healthy living.

Mr. Clement Lam, Chief Executive Officer of Sun Life Hong Kong Limited, stated at the signing ceremony, “Sun Life’s mission is to help clients achieve lifetime financial security and live healthier lives. Our global headquarter in Canada has been supporting basketball development since 2014 and has actively expanded to many regions in Asia in recent years. This partnership with the Basketball Association of Hong Kong, China, will focus on both commercialization and professionalization, leveraging innovation and diverse collaboration to enhance the local basketball ecosystem, fulfilling our corporate mission.”

Three-Year Partnership Covering Three Key Areas to Achieve Sustainable Development
Sun Life is committed to building a sustainable and healthy society and understands the importance of popularization and professionalization for sports development. Therefore, this partnership covers the following three areas.

1. Athlete Support
Sun Life will use its insurance expertise to provide medical and accident insurance for members of the Hong Kong basketball team, addressing the long-standing problem of athlete protection. In addition, to help young players achieve the goal of dual development in sports and academics, Sun Life will fund the establishment of a scholarship program by the BAHKC to provide scholarships for members of the Hong Kong U18 and U22 basketball teams who have successfully enrolled in or are currently attending university. It will also establish a youth player internship program to allow players to prepare for their post-retirement career development through workplace seminars and internship opportunities.

2. Basketball Popularization
To encourage more people to continue participating in basketball and improve their skills, Sun Life will sponsor various basketball competitions, assisting in revolutionizing the games and promoting basketball development. One of the key projects is the “Hong Kong Open Division Men’s and Women’s Basketball League,” which will be title-sponsored by Sun Life. This will be Hong Kong’s first self-financing league with a promotion and relegation system, establishing a clear development pathway for teams and players while strengthening the competitiveness of local basketball. The league will have no age restrictions, and players of any age can sign up to participate and compete in the same event. It is expected to become the largest and most developmental basketball league in Hong Kong, in line with Sun Life’s philosophy of promoting a healthy and active lifestyle and building a healthy and inclusive community. Glen Yang, a member of the Hong Kong, China Basketball Team, who has participated in professional leagues in Canada, Spain, and Taiwan, agrees that the Open-League will be able to attract more players to participate and contribute to the development of basketball in Hong Kong.

From 2025 to 2027, Sun Life will also sponsor the National Day Cup Basketball Tournament, inviting local universities and tertiary institutions to participate, using basketball to promote community cohesion and provide more resource support for sports development in tertiary institutions. The competition will also invite overseas university teams to participate, strengthening exchanges between Asian university basketball teams, encouraging healthy competition, and thereby improving the competitive level of local basketball.

3. Community Outreach
Since 2023, Sun Life has partnered with Beyond Sport, a global foundation promoting sustainable social change through sports, to promote the “Hoops + Health” charity program in Asia, including Hong Kong. Following last year’s collaboration to revitalize the Wah Sum Basketball Court in Fanling, hold basketball coaching workshops, and organize youth basketball activities, this year, they will expand the program and hold free youth basketball workshops in various districts. This encourages young people to develop an optimistic and positive lifestyle, emphasizing both physical and mental well-being.

Mr. Benny Chow, Team Leader of the Youth Team of the Basketball Team of Hong Kong, China, said, “We will work with Sun Life to deepen the promotion of community basketball and connect it with more professional and comprehensive systematic training. We aim to bring new energy into the local basketball, discover and nurture new talent, and attract more young people to join basketball and even develop basketball careers.”

Sun Life and BAHKC Join Forces to Promote a Healthy and Active Lifestyle
Sun Life is committed to promoting basketball, not only to encourage young people to develop healthy living habits through basketball but also to embody the value proposition of Sun Life’s agency team through this passionate sport: “Collaboration,” “Progressive,” and “Impactful.” Mr. Mark Tian, Chief Agency Strategy and Growth Officer of Sun Life Hong Kong Limited stated, “Sun Life values the holistic development of our financial advisors and encourages the team to contribute to the community by actively participating in sports and community activities. Therefore, we have formed a basketball team and will sign up to participate in the Hong Kong Open Division Men’s and Women’s Basketball League sponsored by Sun Life to promote healthy living through action. We hope that through this cooperation, we can showcase Sun Life’s long tradition, dynamic business development, and sustainable future and further embody Sun Life’s team spirit of One Team, One Goal, Win As One.”

Mr. Siu-wong Chan, Executive Vice President and Honorary President of the Basketball Association of Hong Kong, China, added, “Sun Life has been promoting healthy living in different ways and is committed to bringing the community together through sports. Our shared vision for basketball development aligns perfectly. This collaboration will bring new energy to local basketball by not only providing substantial resources to support its growth but also by having Sun Life’s team actively participate in the league. This encourages the public to embrace an active and positive lifestyle.”
Hashtag: #SunLife #BAHKC

The issuer is solely responsible for the content of this announcement.

Finit sells Data to Major Hedge Fund, Expanding Beyond Their B2C Platform Business

Improving inefficiencies can lead to business opportunities 

VIENNA, Va., Feb. 19, 2025 /PRNewswire/ — When an improved method provides value, customers are willing to pay for it.  Finit Co., Ltd., which developed order flow analytics and expanded to the U.S. market through its subsidiary, TradePulse Technologies, Inc., recently sold its Korean stock flow data to a major U.S. top tier high-frequency/ algorithmic trading hedge fund. With its AI-inferred proprietary algorithm, Finit developed major solutions for two separate markets.

  • PowerMap (for Korean stocks)
  • TradePulse (for U.S. stocks)

Their core technology analyzes real-time trading patterns to predict stock trend reversals using AI trained on 15 years of historical data. Currently, the AI utilizes hundreds of thousands of trade patterns to forecast stock movements. For instance, if someone buys 100 shares of Samsung Electronics every minute for two hours, combining this with other characteristics, the system can infer which foreign brokerage is making the purchase. With AI-driven pattern analysis, feature detection, and inference engines, Finit processes hundreds of thousands of trade signals in real time.

In the Korean stock market, investors often wonder who (foreign investors, institutions, or individuals) is buying or selling stocks when making trading decisions. While brokerage trading platforms provide categorized transaction data, they are typically delayed until after 6 PM, well after the market has closed. Only after the market has closed, brokerage firms manually input trading data for foreign investors and institutions. With Finit‘s PowerMap integrated into Korean brokerage apps, users can see real-time predictive trading volumes by category.

With experts capable of implementing Direct Market Access (DMA) and High-Frequency Trading (HFT) technology, Finit was able to develop the PowerMap which processes and delivers large-scale transactions in real time. Processing large volumes of stock transactions instantly requires powerful data processing capabilities. Finit receives direct trade data from exchanges and analyzes buy and sell signals for approximately 1,000 stocks in real time (covering KOSPI stocks with a market cap over 200 billion KRW ($133.38 M) and KOSDAQ stocks over 150 billion KRW ($103.81 M) .

Currently, Finit‘s service PoweMap is available through Korean brokerage apps. However, the company aims to expand to U.S. retail investors, signing contracts with Interactive Brokers, Tradier Brokerage, Quasar Markets, and Cobra Trading to develop tailored solutions such as TradePulse for American investors.

Traditional trading indicators often fail to capture the true market dynamics, relying heavily on past price movements rather than real-time transaction flows. This creates blind spots, especially in fast-moving markets where institutional orders and algorithmic trades can drastically shift stock prices. By processing vast amounts of stock transaction data at high speed and applying AI-driven inference models, TradePulse eliminates these gaps, providing both institutional and retail traders with order flow data in real time, accurately identifying market orders and volumes.

TradePulse, a leading provider of innovative order flow analytics through its proprietary AI-driven algorithm, analyzes over 4,000 U.S. stocks, including Apple, Microsoft, NVIDIA, and Amazon.

“Unlike Korea, U.S. exchanges do not categorize trading data by foreign and institutional investors. Instead, we developed indicators such as large trade volume and buy intensity to predict stock trends.”

For example, if buy intensity and large transactions increase simultaneously within a minute, there is an 84% chance the stock price will rise within three minutes.

Although stock prices may only rise by an average of 1.2% per day, and accuracy is not 100%, TradePulse provides investors with an additional key metric for decision-making.

**About TradePulse**

TradePulse Technologies, Inc. is a leading provider of innovative trading solutions, specializing in order flow analytics. With eight partner companies and no lost partnerships, TradePulse’s technology is highly trusted. The company boasts 2 million page views per day and serves 400,000 users, underscoring its significant market presence and the value it provides to investors.

X | LinkedIn

Tribesigns Ushers in New Era with Newly Updated Logo

NEW YORK, Feb. 19, 2025 /PRNewswire/ — Tribesigns, a globally renowned furniture manufacturer and retailer offering cozy and efficient home and office solutions for every home, is thrilled to announce the debut of its newly redesigned logo, launching on Feb 24th, 2025.

New Logo.
New Logo.

The new logo is an innovative blend of the tent element of primitive tribes and the letter “T”. It is rendered in a geometric design using a flat, planar structure composed of line. Its flat and linear structure creatively symbolizes a blend of a table and a house, reflecting the brand’s core theme of “home.”

Logo Philosophy
Logo Philosophy

Tribesigns’ diverse product portfolio spans multiple furniture categories, including kids’, pet, and office furniture. The updated logo will serve as a shared and symbolic element across all Tribesigns sub-brands, reinforcing the brand’s cohesive identity. 

“This new logo will be widely used in all kinds of Tribesigns brand activities in various channels such as social media, official websites, and e-commerce platforms such Amazon, Walmart, and Wayfair,” said Sophia Zhao, the Chief Product Officer of Tribesigns.

With “Designed for Life” as its slogan, Tribesigns will maintain its commitment to delivering top-tier, unique and innovative home and office solutions worldwide.

Tribesigns offers a comprehensive furniture solution for households and businesses, including the living room, bedroom, home office, hallway, kitchen and dining room. Besides, it has provided various indoor and outdoor furniture products to over 30 million households in the U.S., Canada, Europe and Australia in the past 14 years.

About Tribesigns

Tribesigns is a leading global furniture designer and manufacturer. With the slogan ‘Designed For Life’, its philosophy revolves around the diversity of personal lifestyles and the importance of embracing nature-friendly choices. 

Tribesigns is also widely known for its special and elegant furniture designs, most of its newest models are unique in the market and cannot be found elsewhere, and you will never be disappointed when you choose Tribesigns. With more than 35 overseas warehouses, strong R&D and manufacturing capacities, Tribesigns also offers dropshipping, OEM, and ODM services for business partners

For more information about Tribesigns, please visit https://tribesigns.com/AmazonB2BFacebook,  InstagramYouTubePinterest and TikTok.

Nisun International Partners with Gold of China to Expand Gold Business, Targeting $30-$50 Million in Sales Growth from Venture in 2025

SHANGHAI, Feb. 19, 2025 /PRNewswire/ — Nisun International Enterprise Development Group Co., Ltd (“Nisun International” or the “Company”) (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions provider, today announced a strategic partnership with Gold of China Co., Ltd. (中银金行) (“Gold of China“), a national leader in the gold industry, to expand its gold business segment. This collaboration leverages soaring gold prices and growing market demand, positioning Nisun International to grow its footprint in both the gold retail and wholesale sectors. The projected sales are estimated to be between $30 to $50 million for 2025.

Amid a dynamic global economic landscape, gold has solidified its status as a premier safe-haven asset. In 2025, gold prices have surged to their eighth record high this year, climbing nearly 11% year-to-date following a remarkable 27% increase in 2024. This upward trajectory, driven by gold’s unique commodity, financial, currency, and hedging attributes, has sparked widespread interest from investors worldwide. Against this backdrop, Nisun International is seizing the moment to capitalize on the booming gold market through its alliance with Gold of China, a respected corporation founded in 1992 and approved by the People’s Bank of China (stock code: 871846).

A Comprehensive Gold Industry Platform

The partnership unites Nisun International’s robust supply chain management capabilities with Gold of China’s expertise as one of China’s few national enterprises historically specializing in gold jewelry, both wholesale and retail. Together, the companies are building a comprehensive gold service platform spanning the entire industry chain. Key initiatives include:

  • Centralized Procurement: Nisun International is optimizing procurement processes to ensure reliable, cost-effective gold sourcing, enhancing operational efficiency.
  • Retail Innovation: With rising demand for investment gold bars and other products, Nisun International is introducing innovative marketing strategies and improving customer experiences to meet diverse consumer needs.
  • Wholesale Expansion: The collaboration aims to scale wholesale operations, leveraging Gold of China’s established industry presence.

This multi-faceted approach is designed to strengthen Nisun International’s competitive edge while delivering high-quality gold products and services to both investors and consumers.

Management Commentary

Xin Liu, Chief Executive Officer of Nisun International, commented:
“The gold market’s unprecedented growth presents a transformative opportunity for Nisun International. Our partnership with Gold of China positions us to harness this momentum, expanding our gold business across all channels. We expect this venture to drive significant growth, potentially adding $30 to $50 million in sales in 2025, while reinforcing our commitment to creating value for our stakeholders and customers.”

Market Reception and Future Outlook

Nisun International’s strategic push into the gold industry has already garnered positive market recognition, underscoring the Company’s ability to adapt to evolving economic trends. Looking ahead, Nisun International plans to deepen its collaboration with Gold of China and other strategic partners, exploring new opportunities to innovate within the gold sector and deliver long-term value.

About Nisun International Enterprise Development Group Co., Ltd

Nisun International Enterprise Development Group Co., Ltd (NASDAQ: NISN) is a technology-driven, integrated supply chain solutions provider focused on transforming the corporate finance industry. Leveraging its industry experience, Nisun International is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, Nisun International provides users with professional solutions for technology supply chain management, technology asset routing, and digital transformation of tech and finance institutions, enabling the industry to strengthen and grow. At the same time, Nisun International continues to deepen the field of industry segmentation through industrial and financial integration. Focusing on industry-finance linkages, Nisun International aims to serve the upstream and downstream of the industrial supply chain while also assisting with supply-side sub-sector reform. For more information, please visit http://ir.nisun-international.com/

Cautionary Note Regarding Forward-Looking Statements

This press release contains information about Nisun International ‘s view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. Nisun International encourages you to review other factors that may affect its future results in Nisun International ‘s registration statement and in its other filings with the Securities and Exchange Commission. Nisun International assumes no obligation to update or revise its forward-looking statements as a result of new information, future events or otherwise, except as expressly required by applicable law.

Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

SYDNEY, Feb. 19, 2025 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the United States (US) Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) for 67Cu-SAR-bisPSMA for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been previously treated with androgen receptor pathway inhibition (ARPI).

This milestone builds on Clarity’s earlier receipt of 2 FTDs for the diagnostic 64Cu-SAR-bisPSMA in patients with suspected metastasis of prostate cancer who are candidates for initial definitive therapy[1], as well as patients with biochemical recurrence (BCR) of prostate cancer following definitive therapy[2], with 2 Phase III registration trials underway (CLARIFY [NCT06056830][3] and AMPLIFY, respectively). These 3 FTDs demonstrate the quality of the data generated to date on the 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA products in addressing serious unmet needs in prostate cancer. The FTDs will enable Clarity to accelerate the development of its comprehensive program with the optimised SAR-bisPSMA agent to be used in patients with prostate cancer throughout the management of their cancer, from initial to late-stage disease, with an opportunity to completely change the entire treatment landscape for the large prostate cancer market.

The FDA’s FTD is designed to expedite the development and regulatory review of novel drugs addressing serious conditions with significant unmet medical needs. For SAR-bisPSMA, it provides a number of product development advantages. The designations pave the way for a faster review process once Clarity submits its product approval applications. Additionally, it enables more frequent communication with the FDA, allowing for rapid resolution of queries during development. Furthermore, Clarity can submit completed sections of its application as they are ready, rather than waiting for the entire package to be finished before it can be lodged with the FDA. These benefits would reduce the review time needed to bring this innovative and proprietary molecule to the prostate cancer imaging and therapy markets.

The data for this FTD submission was based on the preliminary results to date from the Phase I/IIa SECuRE study (NCT04868604)[4], which is investigating the safety and efficacy of 67Cu-SAR-bisPSMA for the treatment of mCRPC patients. The first 3 cohorts in the dose escalation phase of the trial were successfully completed with no dose limiting toxicities (DLTs) reported in any of the participants dosed (15 participants). No adverse events (AEs) related to 64Cu-SAR-bisPSMA were observed. Most AEs related to 67Cu-SAR-bisPSMA were low grade (grade 1 or 2). The most common AE reported was mild dry mouth (grade 1, 5/15 participants, 33.3%).

Preliminary data shows that the majority of participants in the SECuRE study enrolled to date had bone metastasis (77%), high median prostate-specific antigen (PSA) level at baseline (112.86 ng/mL, range 0.1-1503.1) and were heavily pre-treated (59% of participants received 3 or more lines of therapy). Despite how heavily pre-treated these participants were, and how much disease they had, 73% of them across all cohorts (including the lowest dose cohort of 67Cu-SAR-bisPSMA at 4 GBq, single dose) showed reductions in PSA levels. The majority of patients that had an increase in PSA were on the single, lowest dose cohort 1 (4 GBq). PSA reductions of greater than 50% were seen in 45% of all trial participants, despite the overwhelming majority of participants only receiving a single dose of 67Cu-SAR-bisPSMA (4, 8 or 12 GBq) in the trial. In cohorts 2, 3 and 4 (8 and 12 GBq single dose and 12 GBq multi-dose, respectively), in which most participants also only received 1 dose of 67Cu-SAR-bisPSMA, PSA reductions of greater than 35% were observed in almost 75% of participants and PSA was reduced by 80% or more in almost half of the participants so far, as patients continue in follow-up.

The trial is currently progressing through the highest dose cohort where participants were administered multiple doses of 12 GBq of 67Cu-SAR-bisPSMA. Recruitment into cohort 4 is complete, and the remaining 3 participants are currently in the safety and efficacy follow-up period after receiving their first 2 doses. Following completion of the follow-up up period, the safety review committee meeting is planned for March 2025. The largest drop in prostate-specific antigen (PSA) in cohort 4 to date is a decline of 98% (from a baseline of 157.4 ng/mL). This participant, who had failed multiple lines of therapy prior to receiving 67Cu-SAR-bisPSMA (androgen deprivation therapy [ADT], ARPI and an investigational agent), has already had a radiographic partial response based on the investigator’s assessment of Response Evaluation Criteria in Solid Tumours v1.1 (RECIST) criteria. Preliminary analysis showed a reduction of 60.6% in tumour volume evaluated by PSMA positron emission tomography [PET] imaging with 64Cu-SAR-bisPSMA.

Cohort expansion of the SECuRE trial to assess the combination of 67Cu-SAR-bisPSMA with enzalutamide

For a long time, Clarity has been working closely with many important global medical experts in the field of prostate cancer, including the Company’s Clinical Advisory Board members, Prof Louise Emmett and Prof Oliver Sartor, to optimise the development of all of its products in prostate cancer. Those discussions have led to a recent protocol amendment for the SECuRE trial, which aims to investigate ways to further improve the treatment outcomes for these patients. The protocol amendment is aligned with the positive results of the Enza-p trial presented by Prof Emmett first at the European Society for Medical Oncology in 2023[5] and more recently at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium in 2025[6], which confirmed the hypothesis that targeting both androgen signalling and PSMA receptors concurrently would improve anti-cancer activity in mCRPC. The latest SECuRE protocol amendment increased the number of participants in the cohort expansion phase from 14 to 24 patients in the mCRPC pre-chemotherapy setting, with a subset of patients to receive the combination therapy of 67Cu-SAR-bisPSMA with enzalutamide. This protocol amendment has now been approved at many of the participating trial sites, and the changes are expected to further enhance the already positive results of 67Cu-SAR-bisPSMA observed in the SECuRE trial to date. This strategy focuses on the commercialisation of the product firstly in the largest market for prostate cancer therapies in mCRPC, with pre-chemotherapy being 3 times larger than the post-chemotherapy setting, and creates opportunities for the use of 67Cu-SAR-bisPSMA with a range of ARPIs in future clinical development. Addressing the radiopharmaceuticals supply issues with current treatments in such a large indication requires a streamlined approach for which Clarity’s 64Cu/67Cu platform is well and uniquely suited.

Clarity’s Executive Chairperson, Dr Alan Taylor, commented, “Receiving 3 FTDs for the one molecule, SAR-bisPSMA, within the last 6 months is an incredible achievement for Clarity, highlighting how impressive our science and development are, the significance of the diagnostic and therapeutic data so far, and the high unmet need for better therapies and diagnostics in prostate cancer.

“The dual-targeted bisPSMA molecule was developed at the benchtop of Australian science with the intent of overcoming the shortfalls of the current generation of PSMA-targeting products. It was optimised with two PSMA ligands, which increases not only the amount of product in the lesions, but also how long the product is retained in the lesions over time, making it an ideal candidate for both diagnosis and therapy. The clinical data in both diagnostic and therapeutic indications that we are generating is remarkable, confirming the results that we initially saw in preclinical development. The granting of FTDs by the US FDA for 3 distinct indications in prostate cancer that we are aiming to address with this product is testament to the incredible work of our team and collaborators. This latest FTD will allow us flexibility to develop 67Cu-SAR-bisPSMA in both pre- and post-chemotherapy patients in the mCRPC setting, with initial focus on the largest market segment. The SECuRE study will also provide invaluable information on the potential of 67Cu-SAR-bisPSMA to be combined with enzalutamide and other ARPIs in future, creating opportunities for the broader use of 67Cu-SAR-bisPSMA in those patients with such high unmet medical need.

“These designations will allow us to work closely with the FDA to facilitate the development process and accelerate the approval of what could become best-in-class therapy and diagnostic agents, and our team and collaborators are committed to making this our priority in order to achieve our ultimate goal of improving treatment outcomes for people with cancer.”

About SAR-bisPSMA

SAR-bisPSMA derives its name from the word “bis”, which reflects a novel approach of connecting two PSMA-targeting agents to Clarity’s proprietary sarcophagine (SAR) technology that securely holds copper isotopes inside a cage-like structure, called a chelator. Unlike other commercially available chelators, the SAR technology prevents copper leakage into the body. SAR-bisPSMA is a Targeted Copper Theranostic (TCT) that can be used with isotopes of copper-64 (Cu-64 or 64Cu) for imaging and copper-67 (Cu-67 or 67Cu) for therapy.

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA are unregistered products. The safety and efficacy of 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA have not been assessed by health authorities such as the US—– FDA or the Therapeutic Goods Administration (TGA). There is no guarantee that these products will become commercially available.

About the SECuRE trial

SECuRE (NCT04868604)[4] is a Phase I/IIa theranostic trial for identification and treatment of an advanced form of prostate cancer, mCRPC. It is a multi-centre, single arm, dose escalation study with a cohort expansion. The aim of this trial is to determine the safety and tolerability of both 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA, as well as the efficacy of 67Cu-SAR-bisPSMA as a therapy. A recent protocol amendment has increased the number of participants in the cohort expansion phase from 14 to 24, and a subset of participants will receive the combination of 67Cu-SAR-bisPSMA with enzalutamide.

About Prostate Cancer

Prostate cancer is the second most common cancer diagnosed in men globally and the fifth leading cause of cancer death in men worldwide[7]. Prostate cancer is the second-leading causes of cancer death in American men. The American Cancer Institute estimates in 2025 there will be about 313,780 new cases of prostate cancer in the U.S. and around 35,770 deaths from the disease[8].

About Clarity Pharmaceuticals

Clarity is a clinical stage radiopharmaceutical company focused on the treatment of serious diseases. The Company is a leader in innovative radiopharmaceuticals, developing Targeted Copper Theranostics based on its SAR Technology Platform for the treatment of cancers in children and adults.
www.claritypharmaceuticals.com

For more information, please contact:

Clarity Pharmaceuticals

Dr Alan Taylor    

Catherine Strong

Executive Chairperson     

Investor/Media Relations

ataylor@claritypharm.com        

c.strong@morrowsodali.com 

+61 406 759 268

References

1.  Clarity Pharmaceuticals. Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA. https://www.claritypharmaceuticals.com/news/fast-track/ 

2.  Clarity Pharmaceuticals. Clarity receives U.S. FDA Fast Track Designation for 64Cu-SAR-bisPSMA in biochemical recurrence of prostate cancer. https://www.claritypharmaceuticals.com/news/ftd-2/ 

3.  ClinicalTrials.gov Identifier: NCT06056830, https://clinicaltrials.gov/study/NCT06056830

4.  ClinicalTrials.gov Identifier: NCT04868604, https://clinicaltrials.gov/ct2/show/NCT04868604

5.  Emmett et al. Enzalutamide and 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer (mCRPC): A randomised, phase II trial: ENZA-p (ANZUP 1901). Annals of Oncology, Volume 34, S1325, 2023.

6.  Emmett et al. Overall survival and quality of life with [177Lu] Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in poor-risk, metastatic, castration-resistant prostate cancer in ENZA-p (ANZUP 1901). American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium, 2025

7.  Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21834

8.  American Cancer Society: Key Statistics for Prostate Cancer, https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html

This announcement has been authorised for release by the Executive Chairperson.